Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

According to the Centers for Disease Control and Prevention ( CDC ), ovarian cancer may cause vaginal bleeding, pelvic pain, ...

Many reproductive cancers, such as ovarian and endometrial cancers, develop silently without noticeable early symptoms.

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Dave Coulier’s wife Melissa Coulier shared an update on how the Full House alum is faring amid his chemotherapy treatment for Non-Hodgkin's lymphoma.

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

GSK (GSK) has received expanded approval from the European Commission for its drug Jemperli, also known as dostarlimab, in the treatment of endometrial cancer. Read more here.

The European Commission approves GSK's Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.